
    
      The MC2-01 cream is designed for optimal patient satisfaction - it quickly absorbs into the
      skin leaving it nicely moisturized allowing patients to move on with daily routines. In this
      trial, subjects who fulfil all inclusion and exclusion criteria are enrolled in the trial and
      will apply one dose of trial medication topically once daily for 8 weeks. The purpose of the
      trial, is to determine the and pharmacokinetic parameters of MC2-01 cream in adolescent
      subjects under maximum use conditions.
    
  